Abstract |
Methyl jasmonate (MJ) has recently attracted attention as a promising antitumoral compound because of its highly specific proapoptotic properties in a wide range of malignancies. However, the high doses required to achieve a therapeutic benefit have limited its clinical development. Here, we hypothesize that the family of inhibitor of apoptosis proteins (IAPs) may inhibit MJ-mediated apoptosis in cancer cells. We combined MJ with the IAPs inhibitor, the second mitochondria-derived activator of caspases ( Smac) peptide to treat bladder cancer cells. The results showed that the combination of MJ and Smac peptide enhanced the apoptosis-inducing effect in a synergistic manner by releasing and activating IAPs-bounding caspase-3. These findings suggest that the inhibition of IAPs could overcome the resistance of cancer cells to MJ.
|
Authors | Xing-yuan Xiao, Guo-song Jiang, Liang Wang, Lei Lv, Fu-Qing Zeng |
Journal | Anti-cancer drugs
(Anticancer Drugs)
Vol. 22
Issue 9
Pg. 853-63
(Oct 2011)
ISSN: 1473-5741 [Electronic] England |
PMID | 21642838
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Acetates
- Antennapedia Homeodomain Protein
- Antineoplastic Agents
- Antp protein, Drosophila
- BIRC5 protein, human
- Cyclopentanes
- Drosophila Proteins
- Fluorescent Dyes
- Inhibitor of Apoptosis Proteins
- Oligopeptides
- Oxylipins
- SMAC peptide
- Survivin
- X-Linked Inhibitor of Apoptosis Protein
- methyl jasmonate
- Caspase 3
- Caspase 9
- Bisbenzimidazole
|
Topics |
- Acetates
(pharmacology)
- Antennapedia Homeodomain Protein
- Antineoplastic Agents
(metabolism, pharmacology)
- Apoptosis
(drug effects)
- Bisbenzimidazole
- Caspase 3
(metabolism)
- Caspase 9
(metabolism)
- Cell Survival
(drug effects)
- Cyclopentanes
(pharmacology)
- Drosophila Proteins
- Drug Evaluation, Preclinical
- Drug Synergism
- Fluorescent Dyes
- HEK293 Cells
- Humans
- Inhibitor of Apoptosis Proteins
(metabolism)
- Molecular Targeted Therapy
- Oligopeptides
(metabolism, pharmacology)
- Oxylipins
(pharmacology)
- Survivin
- Tumor Cells, Cultured
- Urinary Bladder Neoplasms
(drug therapy, metabolism)
- X-Linked Inhibitor of Apoptosis Protein
(metabolism)
|